Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial respiratory chain complexes I and II are essential components of the electron transport chain located in the inner mitochondrial membrane. Complex I (NADH:ubiquinone oxidoreductase) utilizes a flavin mononucleotide (FMN) cofactor to initiate electron transfer from NADH, while Complex II (succinate dehydrogenase) utilizes a flavin adenine dinucleotide (FAD) cofactor to transfer electrons from succinate (Hirst, J. Annu Rev Biochem, 2013; Cecchini, G. Crit Rev Biochem Mol Biol, 2003). These complexes are primary sites for the generation of reactive oxygen species (ROS) and are critical for maintaining the cellular energy balance through ATP production (Brand, M. D. Biochem Soc Trans, 2010). Dysfunction in these complexes is linked to a variety of conditions, including mitochondrial DNA disorders, neurodegenerative diseases like Parkinson's, and metabolic syndromes (Koopman, W. J. et al. N Engl J Med, 2012). In oncology, these complexes are targeted to disrupt the metabolic flexibility of cancer cells, with drugs like metformin and IACS-010759 acting as inhibitors that can interact with the flavin-containing subunits (Wheaton, W. W. et al. Nat Cell Biol, 2014; Molina, J. R. et al. Nat Med, 2018). However, targeting these complexes carries significant risks, such as lactic acidosis and systemic toxicity due to their fundamental role in cellular respiration (Owen, M. R. et al. Biochem J, 2000).
Inhibition of electron transfer at the flavin-containing subunits (FMN in Complex I and FAD in Complex II) of the mitochondrial respiratory chain, leading to decreased ATP production and altered cellular redox state (Hirst, J. Annu Rev Biochem, 2013; Cecchini, G. Crit Rev Biochem Mol Biol, 2003).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial respiratory chain complex I and II (Complex I/II).